Ana Cvetanović
University of Nis(RS)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies, Advanced Breast Cancer Therapies
Most-Cited Works
- → IL‐17 and Glutamate Excitotoxicity in the Pathogenesis of Multiple Sclerosis(2014)99 cited
- → Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study(2021)67 cited
- → CD4+ T cell phenotypes in the pathogenesis of immune thrombocytopenia(2020)55 cited
- → IL-17 signalling in astrocytes promotes glutamate excitotoxicity: Indications for the link between inflammatory and neurodegenerative events in multiple sclerosis(2016)49 cited
- → Targeting triple-negative breast cancer: A clinical perspective(2023)43 cited
- → Deleterious versus protective autoimmunity in multiple sclerosis(2015)29 cited
- → Granulocyte-macrophage colony-stimulating factor as a mediator of autoimmunity in multiple sclerosis(2018)22 cited
- Current and future targets and therapies in metastatic colorectal cancer.(2020)
- Stressful life events and breast cancer risk: a hospital-based case-control study.(2015)
- Young age and pathological features predict breast cancer outcome - report from a dual Institution experience in Serbia.(2016)